Prostate cancer ranks as the third most common cancer in the United States and the fourth most prevalent globally. It is most often diagnosed in men aged between 65 and 74, with the median age at ...

Prostate cancer describes the development of cancer in the prostate. The prostate is a gland in the male reproductive system. The disease normally develops slowly, with symptoms emerging sometime ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity.

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

Prostate cancer symptoms a Mayo Clinic doctor monitors in his own body include changes in urination, blood in the urine, bone ...

Hormone blockade therapy, which includes both oral and injectable options, aims to slow or stop the growth of prostate cancer cells by reducing androgen levels. Injectable hormone blockade therapies, ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

According to the American Cancer Society, prostate cancer mortality varies by state, with the highest death rates in ...